Analyzing Haloperidol Treatment in ICU Patients with Delirium

The chapter delves into the AITICU trial, exploring the impact of haloperidol treatment on critically ill patients with delirium. It details the trial's design, patient characteristics, medication administration, primary outcome results, Bayesian analysis findings, and limitations. The chapter concludes with insights from a large RCT, highlighting decreased mortality but no significant differences in days alive and out of hospital for patients receiving haloperidol.